Dätwyler launches dielectric elastomer actuators with partners
Altdorf/Waterford/Allendorf - Together with its partners Momentive and BSC Computer, Dätwyler is launching dielectric elastomer actuators on the industrial market in 2024. They are covering the entire value chain, from raw materials to control of components for the drive technology.
LUKS Group and ETH Zurich move to strengthen cooperation
Lucerne/Zurich - The Luzerner Kantonsspital Gruppe (LUKS Group) and the Swiss Federal Institute of Technology in Zurich (ETH) are seeking to bring medical care, research and teaching more closely together. In this context, joint chairs are also to be established.
Immunocore turns to Oncobit platform
Schlieren/Abingdon - The British biotechnology company Immunocore will in future make use of the platform developed by Oncobit, a medtech firm and spin-off from the University of Zurich. The tests carried out via this platform allow specific cancer markers to be quantified in clinical trials.
Dagorà Lifestyle Innovation Hub opens in Lugano
Lugano - The newly inaugurated Dagorà Lifestyle Innovation Hub in Lugano is set to become an epicenter for creativity, research and technological innovation. The building houses over 15 companies and the Lifestyle Tech Competence Center across 1,700 square meters.
Google's powerful AI research in Greater Zurich
Switzerland is one of Google’s most important research locations in the world. Here’s an interview with Jennifer Wadsworth, Research Coordinator at the AI Center ETH Zurich, and Behshad Behzadi, Vice President of Engineering at Google Cloud in Zurich, about how excellence in academic research and entrepreneurial innovation are combining in the age of AI.
EthereumZuri.ch 2024 conference to focus on innovation
Zurich - The second EthereumZuri.ch conference will celebrate Ethereum's 10th anniversary. Since it was founded, the Greater Zurich Area has established itself as a global hub for the blockchain industry. Hundreds of participants will attend the conference, which will take place from April 5 to 7 at the University of Zurich.
Zambon Biotech obtains exclusive European license from Amneal
Cadempino/Bridgewater - Zambon Biotech has obtained an exclusive license to seek regulatory approval for and market a Parkinson’s drug produced by U.S. pharmaceutical company Amneal. The novel oral formulation of an existing medicine is currently being reviewed by the U.S. regulatory authority.
UZH team uncovers cause of post-stroke risk
Zurich - A research group from the University of Zurich (UZH) has discovered that the risk of a cerebral hemorrhage increases in stroke patients whose brains are resupplied with blood too quickly after the blood clot has been removed. This happens when vascular bridges between neighboring arterial trees are blocked.
US firm Datasite agrees deal to acquire Sherpany
Zurich/Minneapolis - Sherpany is being acquired by Datasite. In so doing, the company from Minneapolis is expanding its product portfolio for strategic transaction projects with the addition of Sherpany’s board-level meeting management software.
Meet with an expansion expert
Our services are free of charge and include:
- Introduction to key contacts in industry, academia, and government
- Advice on regulatory framework, taxes, labor, market, and setting up a company
- Custom-made fact-finding visits, including office and co-working space